{"id":"NCT01683058","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia","officialTitle":"A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01","primaryCompletion":"2014-02","completion":"2014-02","firstPosted":"2012-09-11","resultsPosted":"2015-03-31","lastUpdate":"2015-03-31"},"enrollment":74,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"Aripiprazole IM Depot","otherNames":[]}],"arms":[{"label":"Aripiprazole IM Depot","type":"EXPERIMENTAL"}],"summary":"The phase 3 Trial 31-12-291 is part of the aripiprazole IM depot clinical development program and has been designed to demonstrate the efficacy and safety of aripiprazole IM depot for the treatment of adults experiencing an acute relapse of schizophrenia. Subjects receive treatment during a 12-week double-blind acute treatment phase. The current trial (31-12-297) will allow the subjects who complete Trial 291 to enter this open label trial at the investigator's discretion, where additional safety and tolerability data will be collected.","primaryOutcome":{"measure":"Percentage of Participants Reporting Treatment Emergent Adverse Events (TEAEs), Severe TEAEs, Discontinued Investigational Medicinal Product (IMP) Due to AEs, Serious TEAEs and Outcome of Death","timeFrame":"Baseline to Week 24","effectByArm":[{"arm":"Aripiprazole IM Depot 400/300 mg","deltaMin":66.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":38,"countries":["United States","Croatia","Latvia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":74},"commonTop":["Weight increased","Akathisia","Weight decreased","Headache","Hyperlipidaemia"]}}